QuellTX
2 followers
Quell's vision is to become a leading engineered Treg cell therapy company. The company will seek to develop next generation engineered T-regulatory cell (Treg) therapies for a range of solid organ transplant and autoimmune conditions.Quell has been founded by Syncona in partnership with six leading... Read more
Org chart
Jodie Albutt
VP, IP
Julien Browne
Associate Director Head Analytical Development
Laura Fry
Head of Cell Processing
Luke Devey
Chief Medical Officer
Luke Henry, PhD
Chief Business Officer
Lyndsay Telakis FCIPD
Vice President, People & Culture
Marc Martinez-Llordella
Co-founder & VP Biology
Paul S Carter
Senior Director MSAT
Chris Sharpe
VP, Regulatory Affairs
Aaron Vernon
Chief Manufacturing Officer
Parveen Kaley
Executive Management Assistant - Chief Manufacturing Officer (cmo) / Deputy EA To Ceo.
